Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D

被引:0
作者
Sanchez, M. L. [1 ,4 ]
McGwin, G., Jr. [2 ,3 ,5 ,6 ]
Duran, S. [1 ,4 ]
Fernandez, M. [1 ,4 ]
Reveille, J. D. [7 ]
Vila, L. M. [8 ]
Alarcon, G. S. [1 ,2 ,4 ,5 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Sch Med, Dept Epidemiol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Sch Med, Dept Surg, Sect Trauma Burns & Crit Care, Birmingham, AL USA
[4] Univ Alabama Birmingham, Sch Publ Hlth, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Sch Publ Hlth, Dept Surg, Sect Trauma Burns & Crit Care, Birmingham, AL 35294 USA
[7] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Rheumatol, Dept Med, Houston, TX USA
[8] Univ Puerto Rico, Div Rheumatol, San Juan, PR 00936 USA
关键词
SF-36; SF-6D; quality of life; lupus; QUALITY-OF-LIFE; 3; ETHNIC-GROUPS; INDIRECT UTILITY MEASURES; RHEUMATOID-ARTHRITIS; SOCIOECONOMIC-STATUS; COLLEGE; CLASSIFICATION; HELPLESSNESS; COVERAGE; CRITERIA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Health related quality of life (HRQOL) over course of the disease was ascertained in SLE patients from LUMINA, a multiethnic US cohort, using the SF-36-derived utility measure, the SF-6D. Methods All available visits were examined to predict HRQOL using either variables from the baseline or enrollment visits or from the preceding visits. The physical and mental component summary (PCS and MCS, respectively) measures of the SF-36 were also examined. A total of 2662 visits from 588 SLE patients were included; 90% of the patients were women, 19% Hispanic-Texans, 17% Hispanic-Puerto Ricans, 35% African Americans and 29% Caucasians. The patients' mean (SD) SF-6D was 0.6 (0.1). Results In multivariable analyses, Hispanic-Texan ethnicity and higher levels of social support were predictors of HRQOL whereas older age, poverty, greater disease activity and damage and higher levels of fatigue, helplessness and abnormal illness-related behaviors were negative predictors. Prior SF-6D was the strongest variable predictive of subsequent HRQOL, when included. The analyses in which the PCS and MCS were examined as end-points were, overall, consistent with the SF-6D results. Conclusion We conclude that the SF-6D index provides an adequate measure of self-perceived HRQOL and that patients' self-perception of HRQOL is influenced by disease and non-disease related factors.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 47 条
[31]   Screening for depression in adults: A summary of the evidence for the US Preventive Services Task Force [J].
Pignone, MP ;
Gaynes, BN ;
Rushton, JL ;
Burchell, CM ;
Orleans, CT ;
Mulrow, CD ;
Lohr, KN .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (10) :765-776
[32]   DIMENSIONS OF ILLNESS BEHAVIOR AS MEASURED BY THE ILLNESS BEHAVIOR QUESTIONNAIRE - A REPLICATION STUDY [J].
PILOWSKY, I .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (01) :53-62
[33]  
Reveille JD, 1998, ARTHRITIS RHEUM, V41, P1161, DOI 10.1002/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO
[34]  
2-K
[35]   Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age [J].
Rinaldi, S ;
Doria, A ;
Salaffi, F ;
Ermani, M ;
Iaccarino, L ;
Ghirardello, A ;
Zampieri, S ;
Sarzi-Puttini, P ;
Gambari, PF ;
Perini, G .
RHEUMATOLOGY, 2004, 43 (12) :1574-1579
[36]   Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status [J].
Stamm, Tanja A. ;
Bauernfeind, Bettina ;
Coenen, Michaela ;
Feierl, Eva ;
Mathis, Mona ;
Stucki, Gerold ;
Smolen, Josef S. ;
Machold, Klaus P. ;
Aringerl, Martin .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (07) :1287-1295
[37]   Endpoints: consensus recommendations from OMERACT IV [J].
Strand, V ;
Gladman, D ;
Isenberg, D ;
Petri, M ;
Smolen, J ;
Tugwell, P .
LUPUS, 2000, 9 (05) :322-327
[38]  
Sutcliffe N, 1999, J RHEUMATOL, V26, P2352
[39]  
Szende A, 2004, PHARMACOECONOMICS, V22, P537
[40]   Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation [J].
Teng, YKO ;
Verburg, RJ ;
Sont, JK ;
van den Hout, WB ;
Breedveld, FC ;
van Laar, JA .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2272-2276